Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

Log in / Sign up

Please sign in to follow a disease.

← Back to home

Alar Pharmaceuticals Inc.

Clinical trials sponsored by Alar Pharmaceuticals Inc., explained in plain language.

New injection aims to help when antidepressants fail

Disease control Completed

This early-stage study tested a new drug called ALA-3000 in 37 adults with treatment-resistant depression — meaning their depression did not get better with standard antidepressants. Participants received either ALA-3000 injections or a placebo, along with a newly started oral an…

Phase 1 • Sponsor: Alar Pharmaceuticals Inc. • Aim: Disease control

Last updated Jun 27, 2026 08:07 UTC